At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
01873 VIVA BIOTECH
Closed 12-16 16:08:20
1.860
-0.090
-4.62%
High1.950Low1.820Vol5.54M
Open1.950D1 Closing1.950Amplitude6.67%
Mkt Cap3.96BTradable Cap3.96BTotal Shares2.13B
T/O10.29MT/O Rate0.26%Tradable Shares2.13B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
$40 Million Investment Gain Fails to Prevent Intraday 15% Plunge: What's VIVA BIOTECH (01873) Worth Now?
Stock News  ·  12-15 20:30
$40 Million Investment Gain Fails to Prevent Intraday 15% Plunge: What's VIVA BIOTECH (01873) Worth Now?
VIVA Biotech's Invested and Incubated Company, Arthrosi, Has Entered Into an Acquisition Agreement With Sobi for a Total Transaction Value of up to US$1.5 Billion.
THOMSON REUTERS  ·  12-15 14:06
VIVA Biotech's Invested and Incubated Company, Arthrosi, Has Entered Into an Acquisition Agreement With Sobi for a Total Transaction Value of up to US$1.5 Billion.
Hong Kong Stocks Movement | VIVA BIOTECH (01873) Surges Over 13% as Investee Arthrosi Reaches Acquisition Deal with Sobi
Stock News  ·  12-15 09:38
Hong Kong Stocks Movement | VIVA BIOTECH (01873) Surges Over 13% as Investee Arthrosi Reaches Acquisition Deal with Sobi
VIVA BIOTECH (01873) Divests Stake in an Investment Incubator Company
Stock News  ·  12-14 19:22
VIVA BIOTECH (01873) Divests Stake in an Investment Incubator Company
VIVA Biotech Sells Minority Stake in Arthrosi Therapeutics for Up to US$1.5 Billion
Reuters  ·  12-14 19:11
VIVA Biotech Sells Minority Stake in Arthrosi Therapeutics for Up to US$1.5 Billion
Viva Biotech Holdings (1873) Announces Grant of 8.58 Million Share Options
Bulletin Express  ·  12-02
Viva Biotech Holdings (1873) Announces Grant of 8.58 Million Share Options
VIVA BIOTECH (01873) Grants 8.58 Million Share Options
Stock News  ·  12-02
VIVA BIOTECH (01873) Grants 8.58 Million Share Options
Hong Kong Stocks Movement | CRO Concept Stocks Plunge Collectively: GENSCRIPT BIO (01548) Drops Over 6%, PHARMARON (03759) Falls Over 4%
Stock News  ·  11-21
Hong Kong Stocks Movement | CRO Concept Stocks Plunge Collectively: GENSCRIPT BIO (01548) Drops Over 6%, PHARMARON (03759) Falls Over 4%
Viva Biotech Holdings (01873) Announces Monthly Return on Share Capital Movements for October 2025
Bulletin Express  ·  11-05
Viva Biotech Holdings (01873) Announces Monthly Return on Share Capital Movements for October 2025
Individual investors among Viva Biotech Holdings' (HKG:1873) largest stockholders and were hit after last week's 7.3% price drop
Simply Wall St.  ·  10-24
Individual investors among Viva Biotech Holdings' (HKG:1873) largest stockholders and were hit after last week's 7.3% price drop
Hong Kong Stocks Movement | Pharmaceutical Stocks Continue Multi-Day Decline Amid Short-Term External Environment Changes, Institutions Remain Optimistic About Long-Term Industry Development Trends
Stock News  ·  10-14
Hong Kong Stocks Movement | Pharmaceutical Stocks Continue Multi-Day Decline Amid Short-Term External Environment Changes, Institutions Remain Optimistic About Long-Term Industry Development Trends
Hong Kong Stock Alert | VIVA BIOTECH (01873) Surges Over 10% in Afternoon Trading as AI Pharmaceutical Business Model Shows Validation, Company Takes Forward-Looking Approach in AI Drug Development
Stock News  ·  10-08
Hong Kong Stock Alert | VIVA BIOTECH (01873) Surges Over 10% in Afternoon Trading as AI Pharmaceutical Business Model Shows Validation, Company Takes Forward-Looking Approach in AI Drug Development
VIVA Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry
THOMSON REUTERS  ·  09-29
VIVA Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry
Hong Kong Stock Alert | VIVA BIOTECH (01873) Surges Over 5% Again as AIDD Industry Accelerates, Company Leads AI Pharmaceutical Development
Stock News  ·  09-25
Hong Kong Stock Alert | VIVA BIOTECH (01873) Surges Over 5% Again as AIDD Industry Accelerates, Company Leads AI Pharmaceutical Development
VIVA BIOTECH (01873) Receives Initial "Buy" Rating as CDMO and Incubation Ecosystem Synergy Opens Growth Opportunities
Stock News  ·  09-10
VIVA BIOTECH (01873) Receives Initial "Buy" Rating as CDMO and Incubation Ecosystem Synergy Opens Growth Opportunities
Hong Kong Stock Alert | VIVA BIOTECH (01873) Surges Nearly 7% in Afternoon Session as First-Half Gross Margin Improves Significantly with Company's Forward-Looking AI Drug Development Strategy
Stock News  ·  09-03
Hong Kong Stock Alert | VIVA BIOTECH (01873) Surges Nearly 7% in Afternoon Session as First-Half Gross Margin Improves Significantly with Company's Forward-Looking AI Drug Development Strategy
Viva Biotech Unveils Breakthrough in Cyclic Peptide Therapeutics, Paving the Way for Drug Discovery Innovation
Reuters  ·  09-02
Viva Biotech Unveils Breakthrough in Cyclic Peptide Therapeutics, Paving the Way for Drug Discovery Innovation
Hong Kong Stocks Movement | VIVA BIOTECH (01873) Surges Over 20% After Earnings Release, Interim Shareholder Profit Up 4.28% YoY, AI Orders Show Growing Trend
Stock News  ·  08-29
Hong Kong Stocks Movement | VIVA BIOTECH (01873) Surges Over 20% After Earnings Release, Interim Shareholder Profit Up 4.28% YoY, AI Orders Show Growing Trend
Stock Track | Viva Biotech Soars 5.15% as AI Drug Development Gains Momentum in Pharma Industry
Stock Track  ·  08-29
Stock Track | Viva Biotech Soars 5.15% as AI Drug Development Gains Momentum in Pharma Industry
Stock Track | Viva Biotech Soars 5.15% as AI Drug Development Gains Momentum in Tech Industry
Stock Track  ·  08-29
Stock Track | Viva Biotech Soars 5.15% as AI Drug Development Gains Momentum in Tech Industry

Introduction

Company Name.
VIVA BIOTECH
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
VIVA Biotech Holdings is an investment holding company. The Company has two segments. The Drug Discovery Services segment provides structure-based drug discovery services to biotech and pharmaceutical clients for preclinical innovative drug development. The Contract Design and Manufacturing (CDMO) and Commercialization Services segment is engaged in contract development and manufacturing services for small molecule Active Pharmaceutical Ingredients (APIs) and intermediates, as well as the trading of APIs, intermediates and finished products. The Company conducts business primarily in the United States, China, Europe and other regions.
Issue price:
--